MicroRNA-941 Expression in Polymorphonuclear Granulocytes Is Not Related to Granulomatosis with Polyangiitis

Autor: Nicolas Rapin, Niels Borregaard, Jesper Brink Svendsen, Jack B. Cowland, Elisabeth Præstekjær Cramer, Bo Baslund
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Jumonji Domain-Containing Histone Demethylases
Neutrophils
lcsh:Medicine
Gene Expression
Biochemistry
Monocytes
Lysine demethylase 6B
White Blood Cells
Animal Cells
Proteinase 3
Gene expression
Medicine and Health Sciences
lcsh:Science
Aged
80 and over

Principal Component Analysis
Multidisciplinary
Messenger RNA
Transfection
Middle Aged
Nucleic acids
Female
Cellular Types
Granulomatosis with polyangiitis
Research Article
Adult
Immune Cells
Myeloblastin
Immunology
CD16
Biology
GPI-Linked Proteins
Autoimmune Diseases
Young Adult
03 medical and health sciences
microRNA
Genetics
medicine
Humans
RNA
Messenger

Wegener Granulomatosis
Non-coding RNA
Blood Cells
030102 biochemistry & molecular biology
lcsh:R
Receptors
IgG

Granulomatosis with Polyangiitis
Biology and Life Sciences
Cell Biology
medicine.disease
Molecular biology
Gene regulation
MicroRNAs
030104 developmental biology
Case-Control Studies
RNA
lcsh:Q
Clinical Immunology
Clinical Medicine
Transcriptome
Granulocytes
Promyelocyte
Zdroj: PLoS ONE
PLoS ONE, Vol 11, Iss 10, p e0164985 (2016)
ISSN: 1932-6203
Popis: Jumonji Domain-Containing Protein 3 (JMJD3)/lysine demethylase 6B (KDM6B) is an epigenetic modulator that removes repressive histone marks on genes. Expression of KDM6B mRNA is elevated in leukocytes from patients with ANCA-associated vasculitis (AAV) and has been suggested to be the reason for higher proteinase 3 (PR3) mRNA expression in these cells due to derepression of PRTN3 gene transcription. MicroRNA-941 (miR-941) has been shown to target KDM6B mRNA and inhibit JMJD3 production. We therefore investigated whether polymorphonuclear granulocytes (PMNs) from patients suffering from granulomatosis with polyangiitis (GPA) have lower expression of miR-941 than healthy control donors as a biological cause for higher JMJD3 levels. We found no significant difference in the degree of maturation of PMNs from GPA patients (n = 8) and healthy controls (n = 11) as determined from cell surface expression of the neutrophil maturation marker CD16 and gene expression profile of FCGR3B. The expression of PRTN3 and KDM6B mRNAs and miR-941 was not significantly different in GPA patients and healthy controls. Transfection of pre-miR-941 into the neutrophil promyelocyte cell line PLB-985 cells did not result in reduction of the KDM6B mRNA level as shown previously in a hepatocellular carcinoma cell line. The amount of PR3 in PMNs from GPA patients and healthy controls was comparable. In conclusion, we found that PRTN3 mRNA, KDM6B mRNA, and miR-941 expression levels in PMNs do not differ between GPA patients and healthy controls, and that miR-941 does not uniformly regulate KDM6B mRNA levels by inducing degradation of the transcript. Thus, decreased miR-941 expression in PMNs cannot be part of the pathogenesis of GPA.
Databáze: OpenAIRE